Shanghai Desano

Shanghai Desano is a prominent Chinese pharmaceutical company specializing in the research, development, and large-scale manufacturing of antiretroviral drugs for the treatment of HIV/AIDS. Founded in 1996 and headquartered in Shanghai, the company has established itself as one of the world's leading suppliers of anti-HIV active pharmaceutical ingredients (APIs) and finished dosage forms. Desano operates as a core subsidiary of the Acebright Group and maintains a significant global footprint through partnerships with organizations like the Medicines Patent Pool and ViiV Healthcare. Their portfolio extends beyond HIV to include treatments for Hepatitis B, Hepatitis C, malaria, and more recently, COVID-19 antivirals. The company is recognized for its vertically integrated supply chain, which allows it to provide affordable, high-quality medications to low- and middle-income countries.